{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:43:04Z","timestamp":1776310984537,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Risk-reducing salpingo-oophorectomy (RRSO) has been associated with approximately 50% breast cancer risk reduction among women with a pathogenic variant in BRCA1 or BRCA2 (BRCA1\/2), a finding that has recently been questioned.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We estimated incidence rates of breast cancer and all cancers combined during 5 years of follow-up among participants selecting RRSO or ovarian cancer screening (OCS) among women with a BRCA1\/2 pathogenic variant or strong breast and\/or ovarian cancer family history. Ovarian or fallopian tube or peritoneal cancer incidence rates were estimated for the OCS group. Breast cancer hazard ratios (HRs) for time-dependent RRSO were estimated using Cox regression with age time-scale (4943 and 4990 women-years in RRSO and OCS cohorts, respectively). All statistical tests were two-sided.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The RRSO cohort included 925 participants, and 1453 participants were in the OCS cohort (381 underwent RRSO during follow-up), with 88 incident breast cancers diagnosed. Among BRCA1\/2 pathogenic variant carriers, a non-statistically significant lower breast cancer incidence was observed in the RRSO compared with the OCS cohort (HR\u2009=\u20090.86, 95% confidence interval \u2009=\u20090.45 to 1.67; P\u2009=\u2009.67). No difference was observed in the overall population or among subgroups stratified by prior breast cancer history or menopausal status. Seven fallopian tube and four ovarian cancers were prospectively diagnosed in the OCS cohort, and one primary peritoneal carcinoma occurred in the RRSO cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These data suggest that RRSO might be associated with reduced breast cancer incidence among women with a BRCA1\/2 pathogenic variant, although the effect, if present, is small. This evolving evidence warrants a thorough discussion regarding the impact of RRSO on breast cancer risk with women considering this intervention.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jncics\/pkz075","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T15:36:35Z","timestamp":1570030595000},"source":"Crossref","is-referenced-by-count":16,"title":["Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)"],"prefix":"10.1093","volume":"4","author":[{"given":"Phuong L","family":"Mai","sequence":"first","affiliation":[{"name":"Clinical Genetics Branch, National Cancer Institute, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9739-8462","authenticated-orcid":false,"given":"Austin","family":"Miller","sequence":"first","affiliation":[{"name":"NRG Oncology, Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-3263","authenticated-orcid":false,"given":"Mitchell H","family":"Gail","sequence":"first","affiliation":[{"name":"Biostatistics Branch, National Cancer Institute, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Skates","sequence":"first","affiliation":[{"name":"Department of Biostatistics Unit, Massachusetts General Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Lu","sequence":"first","affiliation":[{"name":"Department of GYN Oncology, MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E","family":"Sherman","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, and Environmental Epidemiology Branch, National Cancer Institute, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga B","family":"Ioffe","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Maryland Medical Center, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3773-4764","authenticated-orcid":false,"given":"Gustavo","family":"Rodriguez","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, NorthShore University Health System, Evanston, IL"},{"name":"Department of Obstetrics and Gynecology, University of Chicago, Evanston, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Cohn","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Boggess","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Raleigh, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rutherford","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology, Yale University, Norwalk, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah D","family":"Kauff","sequence":"first","affiliation":[{"name":"Gynecology and Clinical Genetics Services, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet S","family":"Rader","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-1771","authenticated-orcid":false,"given":"Kelly-Anne","family":"Phillips","sequence":"first","affiliation":[{"name":"Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A","family":"DiSilvestro","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynecology, Women & Infants Hospital, Providence, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander B","family":"Olawaiye","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Hospital of UPMC, Pittsburgh, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mildred R","family":"Ridgway","sequence":"first","affiliation":[{"name":"OB\/GYN, University of MS Medical Center, Jackson, MS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-9239","authenticated-orcid":false,"given":"Mark H","family":"Greene","sequence":"first","affiliation":[{"name":"Clinical Genetics Branch, National Cancer Institute, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Piedmonte","sequence":"first","affiliation":[{"name":"NRG Oncology, Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5034-4309","authenticated-orcid":false,"given":"Joan L","family":"Walker","sequence":"first","affiliation":[{"name":"Department of OB\/GYN, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"issue":"5","key":"2020042107254484000_pkz075-B1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"23","key":"2020042107254484000_pkz075-B2","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"2020042107254484000_pkz075-B3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"2020042107254484000_pkz075-B4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","article-title":"Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review","volume":"212","author":"Ludwig","year":"2016","journal-title":"Am J Surg"},{"issue":"9","key":"2020042107254484000_pkz075-B5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"2020042107254484000_pkz075-B6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"2020042107254484000_pkz075-B7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"21","key":"2020042107254484000_pkz075-B8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"issue":"11","key":"2020042107254484000_pkz075-B9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2020042107254484000_pkz075-B10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"2020042107254484000_pkz075-B11","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv033","article-title":"Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction","volume":"107","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2020042107254484000_pkz075-B12","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv217","article-title":"RE: breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction","volume":"107","author":"Chai","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2020042107254484000_pkz075-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw177","article-title":"Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kotsopoulos","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2020042107254484000_pkz075-B14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1055-9965.EPI-07-2703","article-title":"A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study","volume":"17","author":"Greene","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"2020042107254484000_pkz075-B15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jnci\/94.11.844","article-title":"Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO","volume":"94","author":"Euhus","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"2020042107254484000_pkz075-B16","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1158\/1078-0432.CCR-15-2750","article-title":"Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA125 testing in women at increased familial risk - combined results from two screening trials","volume":"23","author":"Skates","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"29","key":"2020042107254484000_pkz075-B17","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J Clin Oncol"},{"key":"2020042107254484000_pkz075-B18","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch","year":"1980"},{"issue":"5","key":"2020042107254484000_pkz075-B19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cdp.2004.03.003","article-title":"Bilateral oophorectomy and breast cancer risk reduction among women with a family history","volume":"28","author":"Olson","year":"2004","journal-title":"Cancer Detect Prev"},{"issue":"3","key":"2020042107254484000_pkz075-B20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s10549-012-1985-9","article-title":"Family history and risk of breast cancer: Nurses\u2019 Health Study","volume":"133","author":"Colditz","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"2020042107254484000_pkz075-B21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc.2016.72","article-title":"Hereditary breast and ovarian cancer: new genes in confined pathways","volume":"16","author":"Nielsen","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2020042107254484000_pkz075-B22","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J","article-title":"Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"issue":"5","key":"2020042107254484000_pkz075-B23","first-page":"1361","article-title":"BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis","volume":"60","author":"Schorge","year":"2000","journal-title":"Cancer Res"},{"issue":"8302","key":"2020042107254484000_pkz075-B24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families","volume":"320","author":"Tobacman","year":"1982","journal-title":"Lancet"},{"issue":"34","key":"2020042107254484000_pkz075-B25","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1200\/JCO.2016.68.6725","article-title":"Multigene panels to evaluate hereditary cancer risk: reckless or relevant?","volume":"34","author":"Hall","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"2020042107254484000_pkz075-B26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10689-011-9506-2","article-title":"Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations","volume":"11","author":"Moran","year":"2012","journal-title":"Fam Cancer"},{"issue":"11","key":"2020042107254484000_pkz075-B27","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol"},{"key":"2020042107254484000_pkz075-B28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejca.2016.11.028","article-title":"Linking uterine serous carcinoma to BRCA1\/2-associated cancer syndrome: a meta-analysis and case report","volume":"72","author":"de Jonge","year":"2017","journal-title":"Eur J Cancer"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkz075\/30120246\/pkz075.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jncics\/article-pdf\/4\/1\/pkz075\/33108196\/pkz075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jncics\/article-pdf\/4\/1\/pkz075\/33108196\/pkz075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T07:26:07Z","timestamp":1587453967000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkz075\/5583740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkz075","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,10,10]]},"article-number":"pkz075"}}